MENU
GRFS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Grifols SA (GRFS) Ownership - Who owns Grifols SA?
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
8.72B
P/E Ratio
19.82
Total Cash
565.8M
Projected Growth
0.19
Total Debt
8.82B
Revenue
7.45B
Risk (Beta)
1.33
Dividend Yield
0.02
Total Cash/Share
0.83
Total Debt/Equity
172.98
Revenue/Share
13.20 USD as % of share price
Fundamentals
GRFS
Capitalization
8.72B
P/E Ratio
19.82
Risk (Beta)
1.33
Dividend Yield
0.02
Total Cash
566M
Total Cash/Share
0.83
Total Debt
8.82B
Total Debt/Equity
172.98
Projected Growth (PEG Ratio)
0.19
Revenue/Share (as % of the share price)
13.20%
Revenue
7.45B
ROE
N/A
Book Value
5.17B
P/B Ratio
1.15
Cash Flow
N/A
Earnings
0.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
120M
Current Ratio
2.64
Current Revenue Per Employee
79459.29
Dividends Per Share - Security
0.00
EBITDA
1.62B
Float
N/A
Float - Current
N/A
Gross Income Margin
39.33
Revenue To Assets
1.41
Shares Held By Institutions
3.72B
Shares Outstanding - Current
681M
Total Liabilities
12.2B
Total Volume MTD
N/A
Value
1
Gain YTD
40.099
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRFS showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a manufacturer of plasma-derived biological medicines
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com